Adiponectin Is a Contributing Factor of Low Appendicular Lean Mass in Older Community-Dwelling Women: A Cross-Sectional Study

Inflammation is a chronic, sterile, low-grade inflammation that develops with advanced age in the absence of overt infection and may contribute to the pathophysiology of sarcopenia, a progressive and generalized skeletal muscle disorder. Furthermore, a series of biomarkers linked to sarcopenia occurrence have emerged. To aid diagnostic and treatment strategies for low muscle mass in sarcopenia and other related conditions, the objective of this work was to investigate potential biomarkers associated with appendicular lean mass in community-dwelling older women. This is a cross-sectional study with 71 older women (75 ± 7 years). Dual-energy X-ray absorptiometry was used to assess body composition. Plasmatic blood levels of adipokines (i.e., adiponectin, leptin, and resistin), tumor necrosis factor (TNF) and soluble receptors (sTNFr1 and sTNFr2), interferon (INF), brain-derived neurotrophic factor (BDNF), and interleukins (IL-2, IL-4, IL-5, IL-6, IL-8, and IL-10) were determined by enzyme-linked immunosorbent assay. Older women with low muscle mass showed higher plasma levels of adiponectin, sTNFr1, and IL-8 compared to the regular muscle mass group. In addition, higher adiponectin plasma levels explained 14% of the lower appendicular lean mass. High adiponectin plasmatic blood levels can contribute to lower appendicular lean mass in older, community-dwelling women.

[1]  Tiantian Wang,et al.  Searching for the link between inflammaging and sarcopenia , 2022, Ageing Research Reviews.

[2]  Wen-qing Xie,et al.  Inflammation and sarcopenia: A focus on circulating inflammatory cytokines , 2021, Experimental Gerontology.

[3]  A. Danielewicz,et al.  Cognitive and behavioral factors associated to probable sarcopenia in community-dwelling older adults , 2021, Experimental aging research.

[4]  H. Costa,et al.  Inflammatory and oxidative biomarkers as determinants of functional capacity in patients with COPD assessed by 6-min walk test-derived outcomes , 2021, Experimental Gerontology.

[5]  A. De Luca,et al.  Adiponectin and Sarcopenia: A Systematic Review With Meta-Analysis , 2021, Frontiers in Endocrinology.

[6]  A. Lacerda,et al.  Inflammation Biomarkers Are Independent Contributors to Functional Performance in Chronic Conditions: An Exploratory Study , 2021, International Journal of Medical Science and Health Research.

[7]  C. Cooper,et al.  Sarcopenia: revised European consensus on definition and diagnosis , 2019, Age and ageing.

[8]  Chun-wei Li,et al.  Circulating factors associated with sarcopenia during ageing and after intensive lifestyle intervention , 2019, Journal of cachexia, sarcopenia and muscle.

[9]  René Rizzoli,et al.  Sarcopenia: revised European consensus on definition and diagnosis , 2018, Age and ageing.

[10]  F. Rossi,et al.  Influence of skeletal muscle mass and fat mass on the metabolic and inflammatory profile in sarcopenic and non-sarcopenic overfat elderly , 2018, Aging Clinical and Experimental Research.

[11]  C. Cooper,et al.  Relationships Between Markers of Inflammation and Muscle Mass, Strength and Function: Findings from the Hertfordshire Cohort Study , 2017, Calcified Tissue International.

[12]  Aline A Scianni,et al.  Comparison between parameters of muscle performance and inflammatory biomarkers of non-sarcopenic and sarcopenic elderly women , 2017, Clinical interventions in aging.

[13]  Thomas A. Jackson,et al.  Frailty and sarcopenia: The potential role of an aged immune system , 2017, Ageing Research Reviews.

[14]  M. González-Gay,et al.  Leptin in the interplay of inflammation, metabolism and immune system disorders , 2017, Nature Reviews Rheumatology.

[15]  Z. Ulger,et al.  Serum markers of inflammation and oxidative stress in sarcopenia , 2017, Aging Clinical and Experimental Research.

[16]  P. Abete,et al.  Biomarkers in sarcopenia: A multifactorial approach , 2016, Experimental Gerontology.

[17]  L. Rodríguez-Mañas,et al.  Skeletal Muscle Regulates Metabolism via Interorgan Crosstalk: Roles in Health and Disease. , 2016, Journal of the American Medical Directors Association.

[18]  J. Belizário,et al.  Skeletal muscle wasting and renewal: a pivotal role of myokine IL-6 , 2016, SpringerPlus.

[19]  Katsuhiko Suzuki,et al.  Cytokine expression and secretion by skeletal muscle cells: regulatory mechanisms and exercise effects. , 2015, Exercise immunology review.

[20]  S. Kidambi,et al.  Adiposity distribution influences circulating adiponectin levels. , 2014, Translational research : the journal of laboratory and clinical medicine.

[21]  Maren S Fragala,et al.  The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[22]  L. P. Lustosa,et al.  Comparação da força muscular respiratória entre os subgrupos de fragilidade em idosas da comunidade , 2013 .

[23]  Rahul C. Deo,et al.  Type 2 Innate Signals Stimulate Fibro/Adipogenic Progenitors to Facilitate Muscle Regeneration , 2013, Cell.

[24]  H. Sell,et al.  Adaptive immunity in obesity and insulin resistance , 2012, Nature Reviews Endocrinology.

[25]  A. Rösen‐Wolff,et al.  Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury. , 2012, Clinical immunology.

[26]  K. Kohara,et al.  Leptin in Sarcopenic Visceral Obesity: Possible Link between Adipocytes and Myocytes , 2011, PloS one.

[27]  A. Newman,et al.  Inflammatory markers in population studies of aging , 2011, Ageing Research Reviews.

[28]  E. Giannoni,et al.  Globular Adiponectin as a Complete Mesoangioblast Regulator: Role in Proliferation, Survival, Motility, and Skeletal Muscle Differentiation , 2010, Molecular biology of the cell.

[29]  S. Rubin,et al.  Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[30]  G. Ramponi,et al.  Globular adiponectin induces differentiation and fusion of skeletal muscle cells , 2009, Cell Research.

[31]  M. Febbraio,et al.  Muscle as an endocrine organ: focus on muscle-derived interleukin-6. , 2008, Physiological reviews.

[32]  B. Pedersen,et al.  Physiological roles of muscle-derived interleukin-6 in response to exercise , 2007, Current opinion in clinical nutrition and metabolic care.

[33]  H. Tilg,et al.  Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. , 2004, Biochemical and biophysical research communications.

[34]  S. Heymsfield,et al.  Epidemiology of sarcopenia among the elderly in New Mexico. , 1998, American journal of epidemiology.

[35]  K. Matsushima,et al.  Essential involvement of interleukin‐8 (IL‐8) in acute inflammation , 1994, Journal of leukocyte biology.